In addition, A2M presents anti-tumorigenic activity that acts as an inhibitor of central signaling pathways (e.g., phosphatidylinositol 3-kinase (PI3K), protein kinase B (AKT), and SMAD) and modulates tumor cell adhesion, migration, and growth [70]. The gene discussed is AKT1; the disease is neoplasm.